BIOM-X
BioM-X is a thriving healthcare company which focuses on optical medical device design and integration solutions. They integrate optical, software, electrical, and mechanical technologies and develop the digital optical measurement solutions. Their passionate for entrepreneurship, innovation, unprecedented technical ability, enabled us to achieve remarkable milestones in portable devices for ophthalmologists.
BIOM-X
Social Links:
Industry:
Health Care Mechanical Engineering Software
Address:
Hualien, T'ai-wan, Taiwan
Country:
Taiwan
Website Url:
http://www.biom-x.com
Status:
Active
Contact:
+88638246014
Email Addresses:
[email protected]
Technology used in webpage:
Nginx Baidu Analytics Baidu Share Dingfeng Xinhui
Similar Organizations
BioSy
BioSy is a medical hardware and software company specialized in healthcare solutions.
Newest Events participated
Participated in Computex Taipei 2017
on 2017-05-30 as exhibitor
More informations about "BIOM-X"
About - Biomx
Marina Wolfson, Chief Financial Officer, joined BiomX in December 2019, bringing extensive experience from large pharmaceutical and high-tech companies, as well as venture capital …See details»
Company Information :: BiomX, Inc. (PHGE)
Company. BiomX, Inc. 708 Quince Orchard Rd Suite 205 Gaithersburg, MD 20878 USA [email protected]See details»
BIOMx - Crunchbase Company Profile & Funding
BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and …See details»
BiomX - Org Chart, Teams, Culture & Jobs - The Org
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, …See details»
BiomX - VentureRadar
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as …See details»
Organization: BiomX - Cbonds.com
Organization: BiomX Organization name. BiomX Inc. Country name. Israel Country of registration. USA. Industry. Pharmaceutical Preparation and Biotechnology. Bond debt - Find Any Data on …See details»
BiomX | Phage therapy
Press Releases May 08, 2025 BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025. Events May 15, 2025 2:00 pm EDT First Quarter 2025 Financial Results Conference Call. View All. …See details»
Board of Directors :: BiomX, Inc. (PHGE)
Prior to his role in BiomX, Mr. Solomon was a co-founder, president, and CEO of ProClara (formerly NeuroPhage), which is pioneering an approach to treating neurodegenerative …See details»
BIOMx - Funding, Financials, Valuation & Investors - Crunchbase
BIOMx is registered under the ticker NYSEMKT:PHGE . BIOMx is funded by 16 investors. Cystic Fibrosis Foundation and Deerfield Management are the most recent investors. BIOMx has …See details»
Revolutionizing the Treatment of Serious Infections Through
Complementary approaches taken by BiomX for phage treatment • Enables rapid entry into clinical proof of concept, prior to fixed cocktail design • Could be applied to polymicrobial …See details»
BiomX - Leadership Team - The Org
The Leadership Team at BiomX is responsible for steering the company's strategic direction and fostering collaboration across its scientific, clinical, and operational divisions. Comprising key …See details»
BiomX CEO Jonathan Solomon to Present at Biomed Israel
2 days ago BiomX, Inc. Ben Cohen Head Corporate Communications [email protected] _____ 1 All p-values described in this release are non-adjusted. More in Markets View All. Markets …See details»
BiomX Reports First Quarter 2025 Financial Results and Provides ...
6 days ago “The first quarter of 2025 was a period of exceptional progress for BiomX, both on the corporate front and across our clinical pipeline,” said Jonathan Solomon, Chief Executive …See details»
Our Pipeline - Biomx
We have entered into two collaborations with Boehringer Ingelheim. Our first collaboration with Boehringer Ingelheim was announced in September 2020 (see press release) utilizes the …See details»
Investor Relations :: BiomX, Inc. (PHGE)
Mar 31, 2025 Company. BiomX, Inc. 708 Quince Orchard Rd Suite 205 Gaithersburg, MD 20878 USA [email protected]See details»
BiomX Reports First Quarter 2025 Financial Results and Provides ...
6 days ago In March 2025, BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic foot osteomyelitis (DFO) BX004 Phase 2b study …See details»
Newsroom - Biomx
Mar 31, 2025 Inside BiomX's successful trial with CEO Jonathan Solomon. Mar 31, 2025 Endpoints News - BiomX’s phage therapy succeeds in Phase 2 diabetic bone infection study. …See details»
BiomX Announces the Appointment of Susan Blum to its Board of …
Apr 18, 2024 BiomX Contacts. Investor Relations: LifeSci Advisors, LLC John Fraunces Managing Director (917) 355-2395 [email protected], or. Brian Mullen LifeSci …See details»
Careers - Biomx
WHAT DOES IT MEAN TO BE A PART OF BIOMX? We share a sense of purpose across the organization, with every role. We cultivate and build upon industry-leading, global expertise. …See details»
Presentations :: BiomX, Inc. (PHGE)
Mar 31, 2025 Company. BiomX, Inc. 708 Quince Orchard Rd Suite 205 Gaithersburg, MD 20878 USA [email protected]See details»